Cancer-screening software wins wireless competition

April 19, 2013 by Renee Meiller

A software program for screening for cervical cancer, particularly in developing countries with limited resources, earned the top award and $10,000 in the Qualcomm Wireless Innovation Prize at UW-Madison. The AlgoCerv software enables people with limited medical training to scan Pap smear slides and provide results to a patient before she leaves the clinic. "It was the right mix of having something that was original and meeting a specific key need," said judge Samir Gupta of Qualcomm, about the project. "The real need in industry was quite clear."

Sponsored by San Diego-based global ., the wireless innovation competition at UW-Madison is inspired by the Qualcomm Venture Fest, an internal entrepreneurship challenge designed to develop people and real business ideas.

At UW-Madison, students who participate in the Qualcomm Wireless Innovation Prize develop new wireless technology products, as well as business plans for marketing and selling those products.

A team that developed an inexpensive wearable electronic patch that uses the user's unique gestures to execute a pre-programmed command, such as making a cell phone call or sending a text message, earned second place and $5,000 in the competition. RETE adheres discreetly to the wearer's body somewhat like a temporary tattoo.

The third-place, $2,500 winners designed a wearable pulse oxitelemeter that frequently measures a chronically ill patient's at home and transmits the data to his or her physician through the 3G cellular network. For people who suffer from severe asthma, or , the device reduces the burden of recording and sending this data regularly to their healthcare provider.

The competition's 11 entries also included ideas for a smartphone texting app that incorporates media sharing and social networking features, an eye-tracking interface for mobile devices, and a universal remote that gives users control over any electronic device via a smartphone or tablet computer, among others.

Related Stories

Recommended for you

Combination therapy can prevent cytostatic resistance

November 26, 2015

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...

Forecasting the path of breast cancer in a patient

November 23, 2015

USC researchers have developed a mathematical model to forecast metastatic breast cancer survival rates using techniques usually reserved for weather prediction, financial forecasting and surfing the Web.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.